Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients ‌ S.I. Park, C.R. Felipe, P.G. Machado, R. Garcia, A. Skerjanec, R. Schmouder, H. Tedesco-Silva Jr., J.O. Medina-Pestana

Ստացեք ամբողջական տեքստը

Exploratory calcineurin inhibitor-free regimens in living-related kidney transplant recipients ‌ R. Garcia, P.G. Machado, C.R. Felipe, S.I. Park, G.A. Spinelli, M.F. Franco, H. Tedesco-Silva Jr., J.O. Medina-Pestana

Ստացեք ամբողջական տեքստը

Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function ‌ L.A. Silva, C.R. Felipe, S.I. Park, P. Pinheiro-Machado, R. Garcia, M. Franco, S.R. Moreira, H. Tedesco-Silva Jr., J. Medina-Pestana

Ստացեք ամբողջական տեքստը

Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine ‌ P.G.P. Machado, C.R. Felipe, S.I. Park, R. Garcia, S. Moreira, D. Casarini, M. Franco, F. Alfieri, H. Tedesco-Silva Jr., J.O. Medina-Pestana

Ստացեք ամբողջական տեքստը

Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation ‌ G.A. Spinelli, C.R. Felipe, P.G. Machado, R. Garcia, D.E. Casarini, S.R. Moreira, S.I. Park, H. Tedesco-Silva Jr., J.O. Medina-Pestana

Ստացեք ամբողջական տեքստը